Authors:
Cen, S
Khorchid, A
Gabor, J
Rong, LW
Wainberg, MA
Kleiman, L
Citation: S. Cen et al., Roles of Pr55(gag) and NCp7 in tRNA(3)(LYS) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1, J VIROLOGY, 74(22), 2000, pp. 10796-10800
Authors:
Guan, YJ
Whitney, JB
Diallo, K
Wainberg, MA
Citation: Yj. Guan et al., Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus, J VIROLOGY, 74(19), 2000, pp. 8854-8860
Authors:
Liang, C
Rong, LW
Russell, RS
Wainberg, MA
Citation: C. Liang et al., Deletion mutagenesis downstream of the 5 ' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene, J VIROLOGY, 74(14), 2000, pp. 6251-6261
Authors:
Shen, N
Jette, L
Liang, C
Wainberg, MA
Laughrea, M
Citation: N. Shen et al., Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging, J VIROLOGY, 74(12), 2000, pp. 5729-5735
Authors:
Khorchid, A
Javanbakht, H
Wise, S
Halwani, R
Parniak, MA
Wainberg, MA
Kleiman, L
Citation: A. Khorchid et al., Sequences within Pr160gag-pol affecting the selective packaging of primer tRNA(Lys3) into HIV-1, J MOL BIOL, 299(1), 2000, pp. 17-26
Authors:
Quan, YD
Motakis, D
Buckheit, R
Xu, ZQ
Flavin, MT
Parniak, MA
Wainberg, MA
Citation: Yd. Quan et al., Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase, ANTIVIR TH, 4(4), 1999, pp. 203-209
Authors:
Richard, N
Quan, YD
Salomon, H
Hsu, M
Bedard, J
Harrigan, PR
Rando, R
Mansour, T
Bowlin, TL
Wainberg, MA
Citation: N. Richard et al., Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2 '-deoxy-3 '-oxa-4 '-thiocytidine (dOTC), ANTIVIR TH, 4(3), 1999, pp. 171-177
Authors:
Lin, PF
Gonzalez, CJ
Griffith, B
Friedland, G
Calvez, V
Ferchal, F
Schinazi, RF
Shepp, DH
Ashraf, AB
Wainberg, MA
Soriano, V
Mellors, JW
Colonno, RJ
Citation: Pf. Lin et al., Stavudine resistance: an update on susceptibility following prolonged therapy, ANTIVIR TH, 4(1), 1999, pp. 21-28
Authors:
Germinario, RJ
Colby-Germinario, SP
Acel, A
Chandok, R
Davison, K
Mak, J
Kleiman, L
Faust, E
Wainberg, MA
Citation: Rj. Germinario et al., Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression, AIDS RES H, 15(9), 1999, pp. 829-836
Citation: Ma. Wainberg, The need for microbicides: Why aren't women's groups more involved in the fight against AIDS?, AIDS RES H, 15(5), 1999, pp. 405-406
Authors:
Richard, N
Salomon, H
Oliveira, M
Rando, R
Wainberg, MA
Citation: N. Richard et al., Resistance profiles of (+)2 '-deoxy-3 '-oxa-4 '-thiocytidine and (-)2 '-deoxy-3 '-oxa-4 '-thio-5-fluorocytidine., NUCLEOS NUC, 18(4-5), 1999, pp. 773-778
Authors:
Rubsamen-Waigmann, H
Huguenel, E
Shah, A
Paessens, A
Ruoff, HJ
von Briesen, H
Immelmann, A
Dietrich, U
Wainberg, MA
Citation: H. Rubsamen-waigmann et al., Resistance mutations selected in vivo under therapy with anti-HIV drug HBY097 differ from resistance pattern selected in vitro, ANTIVIR RES, 42(1), 1999, pp. 15-24
Authors:
de Muys, JM
Gourdeau, H
Nguyen-Ba, N
Taylor, DL
Ahmed, PS
Mansour, T
Locas, C
Richard, N
Wainberg, MA
Rando, RF
Citation: Jm. De Muys et al., Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2 '-deoxy-3 '-oxa-4 '-thiocytidine, ANTIM AG CH, 43(8), 1999, pp. 1835-1844
Authors:
Borkow, G
Arion, D
Wainberg, MA
Parniak, MA
Citation: G. Borkow et al., The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3 '-azido-3 '-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1, ANTIM AG CH, 43(2), 1999, pp. 259-263
Authors:
Gu, ZX
Wainberg, MA
Nguyen-Ba, N
L'Heureux, L
de Muys, JM
Bowlin, TL
Rando, RF
Citation: Zx. Gu et al., Mechanism of action and in vitro activity of 1 ',3 '-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants, ANTIM AG CH, 43(10), 1999, pp. 2376-2382
Authors:
Genin, P
Mamane, Y
Kwon, H
LePage, C
Wainberg, MA
Hiscott, J
Citation: P. Genin et al., Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells, VIROLOGY, 261(2), 1999, pp. 205-215